Quenot Jean-Pierre, Binquet Christine, Kara Fady, Martinet Olivier, Ganster Frederique, Navellou Jean-Christophe, Castelain Vincent, Barraud Damien, Cousson Joel, Louis Guillaume, Perez Pierre, Kuteifan Khaldoun, Noirot Alain, Badie Julio, Mezher Chaouki, Lessire Henry, Pavon Arnaud
Crit Care. 2013 Apr 25;17(2):R65. doi: 10.1186/cc12598.
To provide up-to-date information on the prognostic factors associated with 28-day mortality in a cohort of septic shock patients in intensive care units (ICUs).
Prospective, multicenter, observational cohort study in ICUs from 14 French general (non-academic) and university teaching hospitals. All consecutive patients with septic shock admitted between November 2009 and March 2011 were eligible for inclusion. We prospectively recorded data regarding patient characteristics, infection, severity of illness, life support therapy, and discharge.
Among 10,941 patients admitted to participating ICUs between October 2009 and September 2011, 1,495 (13.7%) patients presented inclusion criteria for septic shock and were included. Invasive mechanical ventilation was needed in 83.9% (n=1248), inotropes in 27.7% (n=412), continuous renal replacement therapy in 32.5% (n=484), and hemodialysis in 19.6% (n=291). Mortality at 28 days was 42% (n=625). Variables associated with time to mortality, right-censored at day 28: age (for each additional 10 years) (hazard ratio (HR)=1.29; 95% confidence interval (CI): 1.20-1.38), immunosuppression (HR=1.63; 95%CI: 1.37-1.96), Knaus class C/D score versus class A/B score (HR=1.36; 95%CI:1.14-1.62) and Sepsis-related Organ Failure Assessment (SOFA) score (HR=1.24 for each additional point; 95%CI: 1.21-1.27). Patients with septic shock and renal/urinary tract infection had a significantly longer time to mortality (HR=0.56; 95%CI: 0.42-0.75).
Our observational data of consecutive patients from real-life practice confirm that septic shock is common and carries high mortality in general ICU populations. Our results are in contrast with the clinical trial setting, and could be useful for healthcare planning and clinical study design.
提供有关重症监护病房(ICU)脓毒性休克患者28天死亡率相关预后因素的最新信息。
在法国14家普通(非学术性)和大学教学医院的ICU中进行前瞻性、多中心、观察性队列研究。2009年11月至2011年3月期间收治的所有连续性脓毒性休克患者均符合纳入标准。我们前瞻性地记录了有关患者特征、感染、疾病严重程度、生命支持治疗和出院的数据。
在2009年10月至2011年9月期间入住参与研究ICU的10941例患者中,1495例(13.7%)患者符合脓毒性休克纳入标准并被纳入研究。83.9%(n=1248)的患者需要有创机械通气,27.7%(n=412)的患者需要使用血管活性药物,32.5%(n=484)的患者需要连续性肾脏替代治疗,19.6%(n=291)的患者需要血液透析。第28天的死亡率为42%(n=625)。与28天截尾的死亡时间相关的变量:年龄(每增加10岁)(风险比(HR)=1.29;95%置信区间(CI):1.20-1.38)、免疫抑制(HR=1.63;95%CI:1.37-1.96)、Knaus C/D级评分与A/B级评分相比(HR=1.36;95%CI:1.14-1.62)以及脓毒症相关器官功能衰竭评估(SOFA)评分(每增加1分HR=1.24;95%CI:1.21-1.27)。患有脓毒性休克和肾/尿路感染的患者死亡时间显著延长(HR=0.56;95%CI:0.42-0.75)。
我们对来自实际临床实践的连续性患者的观察数据证实,脓毒性休克在普通ICU人群中很常见且死亡率很高。我们的结果与临床试验情况不同,可能对医疗保健规划和临床研究设计有用。